156 related articles for article (PubMed ID: 17028100)
1. Expression of C-terminal deleted p53 isoforms in neuroblastoma.
Goldschneider D; Horvilleur E; Plassa LF; Guillaud-Bataille M; Million K; Wittmer-Dupret E; Danglot G; de Thé H; Bénard J; May E; Douc-Rasy S
Nucleic Acids Res; 2006; 34(19):5603-12. PubMed ID: 17028100
[TBL] [Abstract][Full Text] [Related]
2. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
[TBL] [Abstract][Full Text] [Related]
4. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
[TBL] [Abstract][Full Text] [Related]
5. Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex.
Wolff A; Technau A; Ihling C; Technau-Ihling K; Erber R; Bosch FX; Brandner G
Oncogene; 2001 Mar; 20(11):1307-17. PubMed ID: 11313875
[TBL] [Abstract][Full Text] [Related]
6. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines.
Davidoff AM; Pence JC; Shorter NA; Iglehart JD; Marks JR
Oncogene; 1992 Jan; 7(1):127-33. PubMed ID: 1741160
[TBL] [Abstract][Full Text] [Related]
8. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
Isaacs JS; Hardman R; Carman TA; Barrett JC; Weissman BE
Cell Growth Differ; 1998 Jul; 9(7):545-55. PubMed ID: 9690622
[TBL] [Abstract][Full Text] [Related]
9. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
Zhang G; Chen F; Cao Y; See WA
Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
[TBL] [Abstract][Full Text] [Related]
10. Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells.
Kurata K; Yanagisawa R; Ohira M; Kitagawa M; Nakagawara A; Kamijo T
Oncogene; 2008 Jan; 27(6):741-54. PubMed ID: 17653088
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
12. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
14. Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma.
Armstrong MB; Bian X; Liu Y; Subramanian C; Ratanaproeksa AB; Shao F; Yu VC; Kwok RP; Opipari AW; Castle VP
Neoplasia; 2006 Nov; 8(11):967-77. PubMed ID: 17132229
[TBL] [Abstract][Full Text] [Related]
15. p53 determines multidrug sensitivity of childhood neuroblastoma.
Xue C; Haber M; Flemming C; Marshall GM; Lock RB; MacKenzie KL; Gurova KV; Norris MD; Gudkov AV
Cancer Res; 2007 Nov; 67(21):10351-60. PubMed ID: 17974978
[TBL] [Abstract][Full Text] [Related]
16. Expression of p53 isoforms in renal cell carcinoma.
Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
[TBL] [Abstract][Full Text] [Related]
17. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
18. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY; Berger SL
Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
[TBL] [Abstract][Full Text] [Related]
19. DNA double-strand break repair activities in mammary epithelial cells--influence of endogenous p53 variants.
Keimling M; Wiesmüller L
Carcinogenesis; 2009 Jul; 30(7):1260-8. PubMed ID: 19429664
[TBL] [Abstract][Full Text] [Related]
20. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Keshelava N; Zuo JJ; Chen P; Waidyaratne SN; Luna MC; Gomer CJ; Triche TJ; Reynolds CP
Cancer Res; 2001 Aug; 61(16):6185-93. PubMed ID: 11507071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]